Earnings Call · Q4 FY2025·2026-03-12

Q4 25EPS -12.73%·Rev n/aQ3 25EPS 0.00%·Rev n/aQ2 25EPS -18.75%·Rev n/aQ1 25EPS -65.63%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

Anthony J. Bergmann — Chief Financial Officer

Linda Marbán — Chief Executive Officer

−0.4%1d on move date+1.1% vs SPY3d−9.0%5d−8.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access